Angina Pectoris Drugs Market: A Marketplace That’s Seeing a Slew of New Entrants and Significant Technological Advances
Research analysts forecast the global angina pectoris drugs market to grow at a CAGR of 4.05% during the period 2017-2021.
(EMAILWIRE.COM, September 09, 2017 ) Angina is a type of chest pain or discomfort caused due to a coronary heart disease, specifically due to reduced blood flow to the heart. For angina pectoris drugs market, beta blockers remain the most preferred line of treatment. However, the treatment market witnesses a strong presence of other drug classes such as calcium channel blockers. Though the market is fragmented, large players such as AstraZeneca, Gilead, Novartis, and Pfizer hold significant positions.
Companies Mentioned:
AstraZeneca, Gilead, Novartis, Pfizer, Bayer HealthCare, Bristol-Myers Squibb, GlaxoSmithKline, Merck , Mylan, and Teva Pharmaceutical.
Request sample copy of this report at: http://www.orbisresearch.com/contacts/request-sample/405517
The report covers the present scenario and the growth prospects of the global angina pectoris drugs market for 2017-2021. To calculate the market size, the report considers sales of branded, generic, and off-label drugs.
The market is divided into the following segments based on geography:
Americas
APAC
EMEA
Research report, Global Angina Pectoris Drugs Market 2017-2021, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.
Key vendors
AstraZeneca
Gilead
Novartis
Pfizer
Other prominent vendors
ABayer HealthCare
Bristol-Myers Squibb
GlaxoSmithKline
Merck
Mylan
Teva Pharmaceutical
Market driver
Increase in chronic diseases
For a full, detailed list, view our report
Market challenge
Highly genericized market
For a full, detailed list, view our report
Market trend
Launch of novel pharmacologic agents
For a full, detailed list, view our report
Key questions answered in this report
What will the market size be in 2020 and what will the growth rate be?
What are the key market trends?
What is driving this market?
What are the challenges to market growth?
Who are the key vendors in this market space?
You can request one free hour of our analyst’s time when you purchase this market report. Details are provided within the report.
Enquire more details of the report at: http://www.orbisresearch.com/contact/purchase/405517
About Us:
Orbis Research (orbisresearch.com) is a single point aid for all your market research requirements. We have vast database of reports from the leading publishers and authors across the globe. We specialize in delivering customized reports as per the requirements of our clients. We have complete information about our publishers and hence are sure about the accuracy of the industries and verticals of their specialization. This helps our clients to map their needs and we produce the perfect required market research study for our clients.
Companies Mentioned:
AstraZeneca, Gilead, Novartis, Pfizer, Bayer HealthCare, Bristol-Myers Squibb, GlaxoSmithKline, Merck , Mylan, and Teva Pharmaceutical.
Request sample copy of this report at: http://www.orbisresearch.com/contacts/request-sample/405517
The report covers the present scenario and the growth prospects of the global angina pectoris drugs market for 2017-2021. To calculate the market size, the report considers sales of branded, generic, and off-label drugs.
The market is divided into the following segments based on geography:
Americas
APAC
EMEA
Research report, Global Angina Pectoris Drugs Market 2017-2021, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.
Key vendors
AstraZeneca
Gilead
Novartis
Pfizer
Other prominent vendors
ABayer HealthCare
Bristol-Myers Squibb
GlaxoSmithKline
Merck
Mylan
Teva Pharmaceutical
Market driver
Increase in chronic diseases
For a full, detailed list, view our report
Market challenge
Highly genericized market
For a full, detailed list, view our report
Market trend
Launch of novel pharmacologic agents
For a full, detailed list, view our report
Key questions answered in this report
What will the market size be in 2020 and what will the growth rate be?
What are the key market trends?
What is driving this market?
What are the challenges to market growth?
Who are the key vendors in this market space?
You can request one free hour of our analyst’s time when you purchase this market report. Details are provided within the report.
Enquire more details of the report at: http://www.orbisresearch.com/contact/purchase/405517
About Us:
Orbis Research (orbisresearch.com) is a single point aid for all your market research requirements. We have vast database of reports from the leading publishers and authors across the globe. We specialize in delivering customized reports as per the requirements of our clients. We have complete information about our publishers and hence are sure about the accuracy of the industries and verticals of their specialization. This helps our clients to map their needs and we produce the perfect required market research study for our clients.
Contact Information:
Orbis Research
Hector Costello
Tel: +1 (214) 884-6817
Email us
----
This press release is posted on EmailWire.com -- a global newswire that provides Press Release Distribution Services with Guaranteed Results
Orbis Research
Hector Costello
Tel: +1 (214) 884-6817
Email us
----
This press release is posted on EmailWire.com -- a global newswire that provides Press Release Distribution Services with Guaranteed Results